Atopic keratoconjunctivitis (AKC): chronic allergic eye disease in adults

Atopic keratoconjunctivitis is a chronic, long-lasting allergic condition of the eyelids and the front surface of the eye. The College of Optometrists says it affects many people who have the skin condition atopic dermatitis, better known as eczema. Allergy UK calls it a rare and serious form of allergic eye disease affecting the front surface of the eye and beneath the eyelids.

It sits within a family of allergic eye diseases. Allergy UK explains that allergic eye disease refers to a group of conditions in which the eyes react to allergens in the environment. Allergic conjunctivitis is the most common form, while vernal and atopic keratoconjunctivitis are the rarer, more serious forms.

Allergy UK describes AKC as often thought of as the adult equivalent of vernal keratoconjunctivitis (VKC), and says it sometimes follows childhood VKC. The College of Optometrists adds that VKC often disappears at puberty but may change into AKC at that time.

Allergy UK sets out the differences in age, season and eczema. VKC tends to be outgrown by puberty, while AKC is most common between the ages of 30 and 50. VKC worsens in spring and summer, while AKC generally occurs in the winter. AKC is often linked with eczema, while eczema may occur in children with VKC but is not always present.

The College of Optometrists gives itching or burning as typical early symptoms. The public summary does not list every feature, and the detailed guidance is written for eye professionals, so this guide does not attempt to catalogue all clinical signs. What matters for patients is that the condition is chronic, may flare, and can cause scarring of the cornea if it is poorly controlled.

The NHS conjunctivitis advice is a useful safety net. It says to ask for an urgent GP appointment or get help from NHS 111 if you have pain in your eyes, sensitivity to light, changes in your vision such as wavy lines or flashing, or very red eyes, because these can be signs of a more serious eye problem. Anyone with known allergic eye disease who develops these changes should be seen promptly rather than managing them at home.

The College of Optometrists says that in the early stages, symptoms such as itching or burning can be controlled with standard anti-allergy medicines combined with a cool compress applied to the closed eyes. Courses of steroid eye drops can be needed when symptoms are more severe.

It also says that cases that do not respond to steroids, or need steroid eye drops for long periods, may benefit from ciclosporin or tacrolimus eye drops or ointment. This approach, known as steroid-sparing treatment, matters because steroid eye drops are not regarded as a long-term solution: Allergy UK makes the same point about steroid drops in the closely related condition VKC.

Many cases need referral to an ophthalmologist for management, who may in turn refer to specialists in other allergic diseases. The close link with eczema means that skin and eye care are often best considered together.

Because AKC is chronic, the goal is steady control and prevention of complications rather than a one-off cure. The College of Optometrists states that long-term treatment is needed to prevent complications such as corneal scarring. Practical steps that sit alongside medical treatment include keeping to the treatment plan, attending follow-up appointments and avoiding rubbing the eyes, which the NHS also advises against in the context of conjunctivitis.

Allergy UK notes that many people with allergic eye disease do not recognise when they need to seek help. If symptoms are changing, if your eyes feel more painful than usual, or if your vision is affected, contact your eye team or seek urgent advice as above.

NHS care for AKC usually starts with a GP or optometrist and moves to hospital eye services if the disease is severe or not responding. Some people also pay privately to see an ophthalmologist or allergy specialist. In either setting the key points are an accurate diagnosis, a clear long-term plan and a route back for review if symptoms flare.